Nanoxort LLC, co-founded by Auburn chemical engineers, is developing a safer iron oxide-based MRI contrast agent to replace toxic gadolinium. Nanoxort graduated from the accelerator and recently won a two-year, $1 million Small Business Innovation Research (SBIR) Phase II grant from the National Science Foundation (NSF) to further develop its technology.
VivoSphere LLC, also co-founded by Auburn chemical engineers, provides 3D tissue-engineered cell culture models for drug discovery and toxicity testing. VivoSphere earned a $350,000 Phase I SBIR grant from the National Institutes of Health’s NCATS program to scale up its high-throughput screening platform for more efficient drug discovery.
Archangel Industries, founded by an Auburn engineering alumna, Archangel develops advanced personalized tactical gear – essentially wearable exoskeletons and equipment – to enhance soldier protection and performance. With guidance from Auburn’s entrepreneurship ecosystem, Archangel graduated from the New Venture Accelerator and secured Department of Defense support through R&D contracts for its next-generation combat gear solutions.
These highlighted companies exemplify Auburn University’s commitment to fostering innovation and entrepreneurship through its New Venture Accelerator program.